Premature cardiovascular disease in chronic renal failure (CRF): A model for an advanced ageing process

Experimental Gerontology

Volumn 45, Issue 10, 2010, Pages 797-800

  Girndt, Matthias ^a   Seibert, Eric ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Ageing; Atherosclerosis; Glycosylation end products; Inflammation; Kidney failure chronic

Indexed keywords

AGING; ANGIOGENESIS; ARTERIOSCLEROSIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CELL AGING; CHRONIC KIDNEY FAILURE; ENDOTHELIUM CELL; GLOMERULUS FILTRATION RATE; HUMAN; INFLAMMATION; KIDNEY FUNCTION; MONOCYTE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR;

AGING; CARDIOVASCULAR DISEASES; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; OXIDATIVE STRESS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 77957015271     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2010.04.003     Document Type: Article

References (38)

1. Amann K., Ritz E. Microvascular disease - the Cinderella of uraemic heart disease. Nephrol. Dial. Transplant. 2000, 15:1493-1503.
2. Anderson S., Halter J.B., Hazzard W.R., Himmelfarb J., Horne F.M., Kaysen G.A., Kusek J.W., Nayfield S.G., Schmader K., Tian Y., Ashworth J.R., Clayton C.P., Parker R.P., Tarver E.D., Woolard N.F., High K.P. Prediction, progression, and outcomes of chronic kidney disease in older adults. J. Am. Soc. Nephrol. 2009, 20:1199-1209.
3. Baylis C. Arginine, arginine analogs and nitric oxide production in chronic kidney disease. Nat. Clin. Pract. Nephrol. 2006, 2:209-220.
4. Carrero J.J., Stenvinkel P., Fellstrom B., Qureshi A.R., Lamb K., Heimburger O., Barany P., Radhakrishnan K., Lindholm B., Soveri I., Nordfors L., Shiels P.G. Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients. J. Intern. Med. 2008, 263:302-312.
5. Chen M.F., Chang C.L., Liou S.Y. Increase in resting levels of superoxide anion in the whole blood of uremic patients on chronic hemodialysis. Blood Purif. 1998, 16:290-300.
6. Coresh J., Selvin E., Stevens L.A., Manzi J., Kusek J.W., Eggers P., Van L.F., Levey A.S. Prevalence of chronic kidney disease in the United States. JAMA 2007, 298:2038-2047.
7. Davies D.F., Shock N.W. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J. Clin. Invest 1950, 29:496-507.
8. de Groot K., Bahlmann F.H., Sowa J., Koenig J., Menne J., Haller H., Fliser D. Uremia causes endothelial progenitor cell deficiency. Kidney Int. 2004, 66:641-646.
9. Diet F., Pratt R.E., Berry G.J., Momose N., Gibbons G.H., Dzau V.J. Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 1996, 94:2756-2767.
10. Diez C., Mohr P., Kuss O., Osten B., Silber R.E., Hofmann H.S. Impact of preoperative renal dysfunction on in-hospital mortality after solitary valve and combined valve and coronary procedures. Ann. Thorac. Surg. 2009, 87:731-736.
11. Fliser D., Franek E., Joest M., Block S., Mutschler E., Ritz E. Renal function in the elderly: impact of hypertension and cardiac function. Kidney Int. 1997, 51:1196-1204.
12. Foley R.N., Parfrey P.S., Sarnak M.J. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis. 1998, 32:S112-S119.
13. Girndt M., Kaul H., Sester U., Ulrich C., Sester M., Georg T., Köhler H. Anti-inflammatory interleukin-10 genotype protects dialysis patients from cardiovascular events. Kidney Int. 2002, 62:949-955.
14. Go A.S., Chertow G.M., Fan D., McCulloch C.E., Hsu C.Y. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N. Engl. J. Med. 2004, 351:1296-1305.
15. Honda H., Qureshi A.R., Heimburger O., Barany P., Wang K., Pecoits-Filho R., Stenvinkel P., Lindholm B. Serum albumin, C-reactive protein, interleukin 6, and fetuin a as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am. J. Kidney Dis. 2006, 47:139-148.
16. Kielstein J.T., Boger R.H., Bode-Boger S.M., Schaffer J., Barbey M., Koch K.M., Frolich J.C. Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. J. Am. Soc. Nephrol. 1999, 10:594-600.
17. Levin A., Singer J., Thompson C.R., Ross H., Lewis M. Prevalent left ventricular hypertrophy in the predialysis population: identifying opportunities for intervention. Am. J. Kidney Dis. 1996, 27:347-354.
18. Longenecker J.C., Coresh J., Powe N.R., Levey A.S., Fink N.E., Martin A., Klag M.J. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the CHOICE Study. J. Am. Soc. Nephrol. 2002, 13:1918-1927.
19. Mailloux L.U., Levey A.S. Hypertension in patients with chronic renal disease. Am. J. Kidney Dis. 1998, 32:S120-S141.
20. Melk A., Schmidt B.M., Takeuchi O., Sawitzki B., Rayner D.C., Halloran P.F. Expression of p16INK4a and other cell cycle regulator and senescence associated genes in aging human kidney. Kidney Int. 2004, 65:510-520.
21. Mönckeberg J.G. Ueber Knochenbildung in der Arterienwand. Virchows Arch. 1902, 167:191-210.
22. Nguyen-Khoa T., Massy Z.A., Witko-Sarsat V., Thevenin M., Touam M., Lambrey G., Lacour B., Drueke T.B., Scamps-Latscha B. Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients. Kidney Int. 1999, 56:747-753.
23. Parfrey P.S., Foley R.N. The clinical epidemiology of cardiac disease in chronic renal failure. J. Am. Soc. Nephrol. 1999, 10:1606-1615.
24. Parfrey P.S., Foley R.N., Harnett J.D., Kent G.M., Murray D.C., Barre P.E. Outcome and risk factors for left ventricular disorders in chronic uraemia. Nephrol. Dial. Transplant. 1996, 11:1277-1285.
25. Ramirez R., Carracedo J., Soriano S., Jimenez R., Martin-Malo A., Rodriguez M., Blasco M., Aljama P. Stress-induced premature senescence in mononuclear cells from patients on long-term hemodialysis. Am. J. Kidney Dis. 2005, 45:353-359.
26. Ridker P.M., Rifai N., Rose L., Buring J.E., Cook N.R. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N. Engl. J. Med. 2002, 347:1557-1565.
27. Rogacev K.S., Ulrich C., Blomer L., Hornof F., Oster K., Ziegelin M., Cremers B., Grenner Y., Geisel J., Schlitt A., Kohler H., Fliser D., Girndt M., Heine G.H. Monocyte heterogeneity in obesity and subclinical atherosclerosis. Eur. Heart J. 2009, 31:369-376.
28. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 1999, 340:115-126.
29. Sarnak M.J. Cardiovascular complications in chronic kidney disease. Am. J. Kidney Dis. 2003, 41:11-17.
30. Scalera F., Borlak J., Beckmann B., Martens-Lobenhoffer J., Thum T., Tager M., Bode-Boger S.M. Endogenous nitric oxide synthesis inhibitor asymmetric dimethyl l-arginine accelerates endothelial cell senescence. Arterioscler. Thromb. Vasc. Biol. 2004, 24:1816-1822.
31. Sester U., Sester M., Heine G., Kaul H., Girndt M., Köhler H. Strong depletion of CD14(+)CD16(+) monocytes during haemodialysis treatment. Nephrol. Dial. Transplant. 2001, 16:1402-1408.
32. Tyralla K., Amann K. Morphology of the heart and arteries in renal failure. Kidney Int. Suppl 2003, 84:S80-S83.
33. Ulrich C., Heine G.H., Garcia P., Reichart B., Georg T., Krause M., Köhler H., Girndt M. Increased expression of monocytic angiotensin converting enzyme in dialysis patients with cardiovascular disease. Nephrol. Dial. Transplant. 2006, 21:1596-1602.
34. Ulrich C., Heine G.H., Seibert E., Fliser D., Girndt M. Circulating monocyte subpopulations with high expression of angiotensin conversion enzyme predict mortality in patients with end-stage renal disease. Nephrol. Dial. Transplant. 2010, 25:2265-2272.
35. Wu H., Chen H., Hu P.C. Circulating endothelial cells and endothelial progenitors as surrogate biomarkers in vascular dysfunction. Clin. Lab. 2007, 53:285-295.
36. Yamagata K., Ishida K., Sairenchi T., Takahashi H., Ohba S., Shiigai T., Narita M., Koyama A. Risk factors for chronic kidney disease in a community-based population: a 10-year follow-up study. Kidney Int. 2007, 71:159-166.
37. Young E.W., Akiba T., Albert J.M., McCarthy J.T., Kerr P.G., Mendelssohn D.C., Jadoul M. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am. J. Kidney Dis. 2004, 44:34-38.
38. Zimmermann J., Herrlinger S., Pruy A., Metzger T., Wanner C. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 1999, 55:648-658.